Skip to main content
Erschienen in: Clinical Research in Cardiology 4/2018

13.11.2017 | Original Paper

Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States

verfasst von: Mahek Shah, Soumya Patnaik, Brijesh Patel, Pradhum Ram, Lohit Garg, Manyoo Agarwal, Sahil Agrawal, Shilpkumar Arora, Nilay Patel, Joyce Wald, Ulrich P. Jorde

Erschienen in: Clinical Research in Cardiology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Recent trends on outcomes in cardiogenic shock (CS) complicating acute myocardial infarction (AMI) suggest improvements in early survival. However, with the ever-changing landscape in management of CS, we sought to identify age-based trends in these outcomes and mechanical circulatory support (MCS) use among patients with both AMI and non-AMI associated shock.

Methods

We queried the 2005–2014 Nationwide Inpatient Sample databases to identify patients with a diagnosis of cardiogenic shock. Trends in the incidence of hospital-mortality, and use of MCS such as intra-aortic balloon pump (IABP), Impella/TandemHeart (IMP), and extra corporeal membrane oxygenation (ECMO) were analyzed within the overall population and among different age-categories (50 and under, 51–65, 66–80 and 81–99 years). We also made comparisons between patient groups admitted with CS complicating AMI and those with non-AMI associated CS.

Results

We studied 144,254 cases of CS, of which 55.4% cases were associated with an AMI. Between 2005 and 2014, an overall decline in IABP use (29.8–17.7%; ptrend < 0.01), and an uptrend in IMP use (0.1–2.6%; ptrend < 0.01), ECMO use (0.3–1.8%; ptrend < 0.01) and in-hospital mortality (44.1–52.5% AMI related, 49.6–53.5% non-AMI related; ptrend < 0.01) was seen. Patients aged 81–99 years had the lowest rate of MCS use (14.8%), whereas those aged 51–65 years had highest rate of MCS use (32.3%). Multivariable analysis revealed that patients aged 51-65 years (aOR 1.46, 95% CI 1.40–1.52; p<0.001), 66–80 years (aOR 2.51, 95% CI 2.39–2.63; p<0.01) and 81–99 years (aOR 5.04, 95% CI 4.78–5.32; p<0.01) had significantly higher hospital mortality compared to patients aged ≤ 50 years. Patients admitted with CS complicating AMI were older and had more comorbidities, but lower hospital mortality (45.0 vs. 48.2%; p < 0.001) when compared to non-AMI related CS. We also noted that the proportion of patients admitted with CS complicating AMI significantly decreased from 2005 to 2014 (65.3–45.6%; ptrend < 0.01) whereas those admitted without an associated AMI increased.

Conclusions

IABP use has declined whereas IMP and ECMO use has increased over time among CS admissions. Older age was associated with an incrementally higher independent risk for hospital mortality. Recent trends indicate an increase in both proportion of patients admitted with CS without associated AMI and in-hospital mortality across all CS admissions irrespective of AMI status.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T et al (2006) Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113(6):e85–e151CrossRefPubMed Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T et al (2006) Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113(6):e85–e151CrossRefPubMed
2.
Zurück zum Zitat Wayangankar SA, Bangalore S, McCoy LA, Jneid H, Latif F, Karrowni W et al (2016) Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the CathPCI Registry. JACC Cardiovasc Interv 9(4):341–351CrossRefPubMed Wayangankar SA, Bangalore S, McCoy LA, Jneid H, Latif F, Karrowni W et al (2016) Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the CathPCI Registry. JACC Cardiovasc Interv 9(4):341–351CrossRefPubMed
3.
Zurück zum Zitat Babaev A1, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS (2005) NRMI Investigators. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294(4):448–454CrossRefPubMed Babaev A1, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS (2005) NRMI Investigators. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 294(4):448–454CrossRefPubMed
4.
Zurück zum Zitat O’Gara P, Kushner F, Ascheim D, Casey D, Chung M, de Lemos J et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127(4):e362–e245 O’Gara P, Kushner F, Ascheim D, Casey D, Chung M, de Lemos J et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127(4):e362–e245
5.
Zurück zum Zitat Werdan K, Gielen S, Ebelt H, Hochman JS (2014) Mechanical circulatory support in cardiogenic shock. Eur Heart J 35(3):156–167CrossRefPubMed Werdan K, Gielen S, Ebelt H, Hochman JS (2014) Mechanical circulatory support in cardiogenic shock. Eur Heart J 35(3):156–167CrossRefPubMed
6.
Zurück zum Zitat O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 82(1):E1–27PubMed O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 82(1):E1–27PubMed
7.
Zurück zum Zitat Alexander KP, Newby LK, Armstrong PW, Cannon CP, Gibler WB, Rich MW et al (2007) Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 115(19):2570–2589CrossRefPubMed Alexander KP, Newby LK, Armstrong PW, Cannon CP, Gibler WB, Rich MW et al (2007) Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 115(19):2570–2589CrossRefPubMed
8.
Zurück zum Zitat Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P et al (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 15(6):676–682 173CrossRef Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P et al (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 15(6):676–682 173CrossRef
9.
Zurück zum Zitat Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJ et al (2017) Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol 24(3):278–287 69CrossRef Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJ et al (2017) Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. J Am Coll Cardiol 24(3):278–287 69CrossRef
10.
Zurück zum Zitat Agarwal S, Sud K, Martin J, Menon V (2015) Trends in the Use of Mechanical Circulatory Support Devices in Patients Presenting With ST-Segment Elevation Myocardial Infarction. JACC: Cardiovasc Interv 8(13):1772–1774 Agarwal S, Sud K, Martin J, Menon V (2015) Trends in the Use of Mechanical Circulatory Support Devices in Patients Presenting With ST-Segment Elevation Myocardial Infarction. JACC: Cardiovasc Interv 8(13):1772–1774
11.
Zurück zum Zitat Sandhu A, McCoy L, Negi S, Atri P, Al’Aref S, Curtis J et al (2015) Use of mechanical circulatory support in patients undergoing percutaneous coronary intervention. Circulation 132(13):1243–1251CrossRefPubMed Sandhu A, McCoy L, Negi S, Atri P, Al’Aref S, Curtis J et al (2015) Use of mechanical circulatory support in patients undergoing percutaneous coronary intervention. Circulation 132(13):1243–1251CrossRefPubMed
12.
Zurück zum Zitat Scheidt S, Wilner G, Mueller H, Summers D, Lesch M, Wolff G et al (1973) Intra-aortic balloon counterpulsation in cardiogenic shock—report of a cooperative clinical trial. N Engl J Med 288(19):979–984CrossRefPubMed Scheidt S, Wilner G, Mueller H, Summers D, Lesch M, Wolff G et al (1973) Intra-aortic balloon counterpulsation in cardiogenic shock—report of a cooperative clinical trial. N Engl J Med 288(19):979–984CrossRefPubMed
14.
Zurück zum Zitat Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R et al (2008) A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 52(19):1584–1588CrossRefPubMed Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R et al (2008) A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 52(19):1584–1588CrossRefPubMed
15.
Zurück zum Zitat Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J et al (2013) Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 382(9905):1638–1645CrossRefPubMed Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J et al (2013) Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 382(9905):1638–1645CrossRefPubMed
16.
Zurück zum Zitat Wijns W, Kolh P, Danchin N, DiMario C, Falk V, Folliguet T et al (2010) Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 31(20):2501–2555CrossRefPubMed Wijns W, Kolh P, Danchin N, DiMario C, Falk V, Folliguet T et al (2010) Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 31(20):2501–2555CrossRefPubMed
17.
Zurück zum Zitat Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V et al (2014) Authors/Task Force members. 2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35(37):2541–2619CrossRefPubMed Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V et al (2014) Authors/Task Force members. 2014 ESC/EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35(37):2541–2619CrossRefPubMed
18.
Zurück zum Zitat O’Gara PT, Kushner FG, Ascheim DD (2013) ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62(11):485–510 O’Gara PT, Kushner FG, Ascheim DD (2013) ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62(11):485–510
19.
Zurück zum Zitat Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B (2011) ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 124(23):e574–e651CrossRefPubMed Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B (2011) ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 124(23):e574–e651CrossRefPubMed
20.
Zurück zum Zitat Kolte D, Khera S, Aronow WS, Mujib M, Palaniswami C, Sule S et al (2014) Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc 3(1):e000590CrossRefPubMedPubMedCentral Kolte D, Khera S, Aronow WS, Mujib M, Palaniswami C, Sule S et al (2014) Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States. J Am Heart Assoc 3(1):e000590CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Goldberg RJ, Makam RCP, Yarzebski J, McManus DD, Lessard D, Gore JM (2016) Decade Long Trends (2001–2011) In the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction: Goldberg et al: Cardiogenic Shock and AMI. Circulation Cardiovasc Qual Outcomes 9(2):117–125 Goldberg RJ, Makam RCP, Yarzebski J, McManus DD, Lessard D, Gore JM (2016) Decade Long Trends (2001–2011) In the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction: Goldberg et al: Cardiogenic Shock and AMI. Circulation Cardiovasc Qual Outcomes 9(2):117–125
22.
Zurück zum Zitat Lindenauer PK, Lagu T, Shieh MS, Pekow PS, Rothberg MB (2012) Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003–2009. JAMA 307(13):1405–1413 Lindenauer PK, Lagu T, Shieh MS, Pekow PS, Rothberg MB (2012) Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003–2009. JAMA 307(13):1405–1413
23.
Zurück zum Zitat Polgreen LA, Suneja M, Tang F, Carter BL, Polgreen PM (2015) Increasing trend in admissions for malignant hypertension and hypertensive encephalopathy in the United States. Hypertension 65(5):1002–1007CrossRefPubMed Polgreen LA, Suneja M, Tang F, Carter BL, Polgreen PM (2015) Increasing trend in admissions for malignant hypertension and hypertensive encephalopathy in the United States. Hypertension 65(5):1002–1007CrossRefPubMed
25.
Zurück zum Zitat Aso S, Matsui H, Fushimi K, Yasunaga H (2016) In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation: analysis of 5263 patients using a national inpatient database in Japan. Crit Care 20:80CrossRefPubMedPubMedCentral Aso S, Matsui H, Fushimi K, Yasunaga H (2016) In-hospital mortality and successful weaning from venoarterial extracorporeal membrane oxygenation: analysis of 5263 patients using a national inpatient database in Japan. Crit Care 20:80CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Lauten A, Engström AE, Jung C, Empen K, Erne P, Cook S et al (2013) Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail 6(1):23–30CrossRefPubMed Lauten A, Engström AE, Jung C, Empen K, Erne P, Cook S et al (2013) Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry. Circ Heart Fail 6(1):23–30CrossRefPubMed
27.
Zurück zum Zitat Khera R, Cram P, Lu X, Vyas A, Gerke A, Rosenthal G et al (2015) Trends in the Use of Percutaneous Ventricular Assist Devices: Analysis of National Inpatient Sample Data, 2007 Through 2012. JAMA Int Med 175(6):941–950 Khera R, Cram P, Lu X, Vyas A, Gerke A, Rosenthal G et al (2015) Trends in the Use of Percutaneous Ventricular Assist Devices: Analysis of National Inpatient Sample Data, 2007 Through 2012. JAMA Int Med 175(6):941–950
28.
Zurück zum Zitat Prasad A, Lennon RJ, Rihal CS, Berger PB, Holmes DR Jr (2004) Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularization. Am Heart J 147(6):1066–1070CrossRefPubMed Prasad A, Lennon RJ, Rihal CS, Berger PB, Holmes DR Jr (2004) Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularization. Am Heart J 147(6):1066–1070CrossRefPubMed
29.
Zurück zum Zitat Aissaoui N, Puymirat E, Juilliere Y, Jourdain P, Blanchard D, Schiele F (2016) Fifteen-year trends in the management of cardiogenic shock and associated 1-year mortality in elderly patients with acute myocardial infarction: the FAST-MI programme. Eur J Heart Fail 18(9):1144–1152CrossRefPubMed Aissaoui N, Puymirat E, Juilliere Y, Jourdain P, Blanchard D, Schiele F (2016) Fifteen-year trends in the management of cardiogenic shock and associated 1-year mortality in elderly patients with acute myocardial infarction: the FAST-MI programme. Eur J Heart Fail 18(9):1144–1152CrossRefPubMed
30.
Zurück zum Zitat Alexander KP, Newby LK, Armstrong PW, Cannon CP, Gibler WB, Rich MW et al (2007) Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 115(19):2570–2589CrossRefPubMed Alexander KP, Newby LK, Armstrong PW, Cannon CP, Gibler WB, Rich MW et al (2007) Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 115(19):2570–2589CrossRefPubMed
31.
Zurück zum Zitat Klein LW, Shaw RE, Krone RJ, Brindis RG, Anderson HV, Block PC et al (2005) Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. Am J Cardiol 96(1):35–41CrossRefPubMed Klein LW, Shaw RE, Krone RJ, Brindis RG, Anderson HV, Block PC et al (2005) Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. Am J Cardiol 96(1):35–41CrossRefPubMed
32.
Zurück zum Zitat Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LS, van Domburg RT, Serruys PW (2009) Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 30(17):2102–2108CrossRefPubMed Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LS, van Domburg RT, Serruys PW (2009) Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J 30(17):2102–2108CrossRefPubMed
33.
Zurück zum Zitat Thiele H, Sick P, Boudriot E, Diederich K, Hambrecht R, Niebauer J, Schuler G (2005) Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 26(13):1276–1283CrossRefPubMed Thiele H, Sick P, Boudriot E, Diederich K, Hambrecht R, Niebauer J, Schuler G (2005) Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 26(13):1276–1283CrossRefPubMed
34.
Zurück zum Zitat Shah AP, Retzer EM, Nathan S, Paul JD, Friant J, Dill KE, Thomas JL (2015) Clinical and economic effectiveness of percutaneous ventricular assist devices for high-risk patients undergoing percutaneous coronary intervention. J Invasive Cardiol 27(3):148–154PubMed Shah AP, Retzer EM, Nathan S, Paul JD, Friant J, Dill KE, Thomas JL (2015) Clinical and economic effectiveness of percutaneous ventricular assist devices for high-risk patients undergoing percutaneous coronary intervention. J Invasive Cardiol 27(3):148–154PubMed
35.
Zurück zum Zitat Gregory D, Scotti DJ, de Lissovoy G, Palacios I, Dion S, Maini B et al (2013) A Value-Based Analysis of Hemodynamic Support Strategies for High-Risk Heart Failure Patients Undergoing a Percutaneous Coronary Intervention. Am Health Drug Benefits 6(2):88–99PubMedPubMedCentral Gregory D, Scotti DJ, de Lissovoy G, Palacios I, Dion S, Maini B et al (2013) A Value-Based Analysis of Hemodynamic Support Strategies for High-Risk Heart Failure Patients Undergoing a Percutaneous Coronary Intervention. Am Health Drug Benefits 6(2):88–99PubMedPubMedCentral
Metadaten
Titel
Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States
verfasst von
Mahek Shah
Soumya Patnaik
Brijesh Patel
Pradhum Ram
Lohit Garg
Manyoo Agarwal
Sahil Agrawal
Shilpkumar Arora
Nilay Patel
Joyce Wald
Ulrich P. Jorde
Publikationsdatum
13.11.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 4/2018
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-017-1182-2

Weitere Artikel der Ausgabe 4/2018

Clinical Research in Cardiology 4/2018 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.